scholarly article | Q13442814 |
P50 | author | Kim Cornish | Q1741621 |
Darren R Hocking | Q89285729 | ||
Alison D Archibald | Q101147543 | ||
Yoshimi Inaba | Q123050466 | ||
Howard R Slater | Q123050473 | ||
Mark A. Bellgrove | Q30537281 | ||
Minh Bui | Q39063603 | ||
Julian N. Trollor | Q46612412 | ||
Erin Turbitt | Q56923501 | ||
David E Godler | Q56996913 | ||
Sylvia A Metcalfe | Q64834125 | ||
Claudine Kraan | Q86064363 | ||
P2093 | author name string | Jonathan Cohen | |
Xin Li | |||
P2860 | cites work | Epigenetic programming by maternal behavior | Q27860466 |
CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing | Q28249503 | ||
Transcription-associated R-loop formation across the human FMR1 CGG-repeat region | Q28537978 | ||
Epigenetic regulation in psychiatric disorders | Q29616296 | ||
Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. | Q33527737 | ||
Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism | Q33617809 | ||
CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. | Q33649307 | ||
FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles | Q33949054 | ||
An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis | Q34084834 | ||
Premature ovarian failure in the fragile X syndrome | Q34306135 | ||
The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories | Q34309145 | ||
Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome | Q34407383 | ||
FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cells | Q34530652 | ||
Social phobia | Q34559590 | ||
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers. | Q34721602 | ||
CGG-repeat length threshold for FMR1 RNA pathogenesis in a cellular model for FXTAS | Q34955465 | ||
R-loops associated with triplet repeat expansions promote gene silencing in Friedreich ataxia and fragile X syndrome. | Q35160930 | ||
Prevalence of CGG expansions of the FMR1 gene in a US population-based sample | Q36082674 | ||
Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum | Q36450321 | ||
Anxiety and cognitive performance: attentional control theory | Q36828105 | ||
DNA methylation in mouse embryonic stem cells and development. | Q37024892 | ||
Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome. | Q37503306 | ||
Genome-wide alteration of 5-hydroxymethylcytosine in a mouse model of fragile X-associated tremor/ataxia syndrome | Q37508604 | ||
Neurobehavioural evidence for the involvement of the FMR1 gene in female carriers of fragile X syndrome | Q38076961 | ||
Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study | Q39260899 | ||
Cognitive-motor interference during postural control indicates at-risk cerebellar profiles in females with the FMR1 premutation | Q39376126 | ||
CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus | Q40789249 | ||
Integrating Mediators and Moderators in Research Design. | Q42023875 | ||
CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome | Q42068973 | ||
Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. | Q44610465 | ||
Analysis of the molecular parameters that could predict the risk of manifesting premature ovarian failure in female premutation carriers of fragile X syndrome | Q45061560 | ||
Mood and anxiety disorders in females with the FMR1 premutation | Q45582526 | ||
Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers. | Q46708960 | ||
Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spots | Q46853263 | ||
Genotype-phenotype relationship in female carriers of the premutation and full mutation of FMR-1. | Q50301648 | ||
Risk of cognitive impairment in female premutation carriers of fragile X premutation: analysis by means of robust segmented linear regression models. | Q51697962 | ||
Evidence that homologous X-chromosome pairing requires transcription and Ctcf protein. | Q51731749 | ||
Genotype, molecular phenotype, and cognitive phenotype: correlations in fragile X syndrome. | Q51985536 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phenotype | Q104053 |
P304 | page(s) | 1631-1638 | |
P577 | publication date | 2015-03-25 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Novel methylation markers of the dysexecutive-psychiatric phenotype in FMR1 premutation women | |
P478 | volume | 84 |
Q90950470 | Abnormally Methylated FMR1 in Absence of a Detectable Full Mutation in a U.S.A Patient Cohort Referred for Fragile X Testing |
Q28087781 | Advanced technologies for the molecular diagnosis of fragile X syndrome |
Q49813454 | An emerging role for epigenetic factors in relation to executive function. |
Q37622638 | Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females. |
Q92934722 | Clinical and Molecular Differences between 4-Year-Old Monozygous Male Twins Mosaic for Normal, Premutation and Fragile X Full Mutation Alleles |
Q46017813 | Clinical and molecular correlates in fragile X premutation females. |
Q40776996 | Executive Dysfunction in Female FMR1 Premutation Carriers. |
Q64068791 | Incomplete silencing of full mutation alleles in males with fragile X syndrome is associated with autistic features |
Q50301216 | Intragenic DNA methylation in buccal epithelial cells and intellectual functioning in a paediatric cohort of males with fragile X. |
Q92203559 | Language processing skills linked to FMR1 variation: A study of gaze-language coordination during rapid automatized naming among women with the FMR1 premutation |
Q38880543 | Neuropsychiatry of fragile X-premutation carriers with and without fragile X-associated tremor-ataxia syndrome: implications for neuropsychology |
Q33629743 | Reduced vagal tone in women with the FMR1 premutation is associated with FMR1 mRNA but not depression or anxiety. |
Q47297403 | The effects of optimism, religion, and hope on mood and anxiety disorders in women with the FMR1 premutation. |
Q36522702 | Trajectory and Predictors of Depression and Anxiety Disorders in Mothers With the FMR1 Premutation |
Q37076523 | β-glucuronidase mRNA levels are correlated with gait and working memory in premutation females: understanding the role of FMR1 premutation alleles |
Search more.